文献速递类风湿关节炎

HLA-B*08 被确定为抗氨甲酰化蛋白抗体阳性/抗环瓜氨酸肽抗体阴性类风湿关节炎最显著相关的 MHC 位点

HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2021-04-23

该研究聚焦抗CCP抗体阴性的RA患者,在西班牙、瑞典和荷兰的1,821例抗CCP- RA患者与6,821例人群对照中评估约8,000个MHC双等位基因变异。结果显示HLA-B*08及其相关氨基酸变异Asp-9与抗CarP+/抗CCP- RA显著相关(P < 3.78 × 10-7;I2 = 0),且该关联相对于三个人群对照具有特异性;校正HLA-B*08后无其他MHC变异保留关联,HLA-DRB1*03的关联归因于连锁不平衡。

要点

  • HLA-B*08及其Asp-9变异与抗CarP+/抗CCP- RA显著相关。
  • 该关联相对于人群对照及其他抗体亚组具有特异性。
  • 校正HLA-B*08后,HLA-DRB1*03关联归因于连锁不平衡。

核心结论

  • HLA-B*08(携带Asp-9)是抗CarP+/抗CCP- RA最显著相关的MHC位点。

研究设计与样本

  • 研究纳入西班牙、瑞典和荷兰的1,821例抗CCP- RA患者和6,821例人群对照,对约8,000个MHC双等位基因变异进行密集基因分型和填充,采用 logistic 回归和逆方差荟萃分析,研究特异性显著性阈值为P < 2.0 × 10-5。

主要发现

  • HLA-B*08等位基因及其相关氨基酸变异Asp-9与抗CarP+/抗CCP- RA显著相关(P < 3.78 × 10-7;I2 = 0)。
  • 该关联相对于人群对照、抗CarP-/抗CCP- RA患者和其他抗瓜氨酸化蛋白抗体阳性的抗CCP- RA患者三个比较组均具有特异性。
  • 校正HLA-B*08后,无其他MHC变异与抗CarP+/抗CCP- RA保留关联。
  • HLA-DRB1*03的关联水平与既往报道相当,但归因于连锁不平衡。

关键数值与推荐

  • 研究特异性显著性阈值为P < 2.0 × 10-5。
  • HLA-B*08与抗CarP+/抗CCP- RA关联的P < 3.78 × 10-7,I2 = 0。

临床怎么用

  • HLA-B*08(携带Asp-9)可作为抗CarP+/抗CCP- RA的MHC易感标记,有助于区分该抗体定义亚型。
  • 解读HLA-DRB1*03与抗CarP+/抗CCP- RA的关联时需考虑其与HLA-B*08的连锁不平衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previously, only the HLA-DRB1 alleles have been assessed in rheumatoid arthritis (RA). The aim of the present study was to identify the key major histocompatibility complex (MHC) susceptibility factors showing a significant association with anti-carbamylated protein antibody-positive (anti-CarP+) RA. METHODS: Analyses were restricted to RA patients who were anti-cyclic citrullinated peptide antibody negative (anti-CCP-), because the anti-CCP status dominated the results otherwise. Therefore, we studied samples from 1,821 anti-CCP- RA patients and 6,821 population controls from Spain, Sweden, and the Netherlands. The genotypes for ~8,000 MHC biallelic variants were assessed by dense genotyping and imputation. Their association with the anti-CarP status in RA patients was tested with logistic regression and combined with inverse-variance meta-analysis. Significance of the associations was assessed according to a study-specific threshold of P < 2.0 × 10-5 . RESULTS: The HLA-B*08 allele and its correlated amino acid variant Asp-9 showed a significant association with anti-CarP+/anti-CCP- RA (P < 3.78 × 10-7 ; I2 = 0). This association was specific when assessed relative to 3 comparator groups: population controls, anti-CarP-/anti-CCP- RA patients, and anti-CCP- RA patients who were positive for other anti-citrullinated protein antibodies. Based on these findings, anti-CarP+/anti-CCP- RA patients could be separated from other antibody-defined subsets of RA patients in whom an association with the HLA-B*08 allele has been previously demonstrated. No other MHC variant remained associated with anti-CarP+/anti-CCP- RA after accounting for the presence of the HLA-B*08 allele. Specifically, the reported association of HLA-DRB1*03 was observed at a level comparable to that reported previously, but it was attributable to linkage disequilibrium. CONCLUSION: These results identify HLA-B*08 carrying Asp-9 as the MHC locus showing the strongest association with anti-CarP+/anti-CCP- RA. This knowledge may help clarify the role of the HLA in susceptibility to specific subsets of RA, by shaping the spectrum of RA autoantibodies.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Regueiro C, Casares-Marfil D, Lundberg K, et al. HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33381897. doi:10.1002/art.41630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。